NONTRANSPLANT TREATMENT OF TYROSINEMIA
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
LINDSTEDT, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92685-9 · Cited by 631
Self-citationOn the enzymic defects in hereditary tyrosinemia.
Lindblad, B., Lindstedt, S., & Steen, G. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4641 · Cited by 447
Self-citationThe occurrence of hepatoma in the chronic form of hereditary tyrosinemia
Weinberg, A. G., Mize, C. E., & Worthen, H. G. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80259-4 · Cited by 283
Tyrosinaemia type I and NTBC (2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1,3‐cyclohexanedione)
Holme, E., & Lindstedt, S. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005410820201 · Cited by 264
Self-citationVan Spronsen, F. J., Thomasse, Y., Smit, P. G. A., Leonard, J. V., Clayton, P. T., Fidler, V., Berger, R., & Heymans, H. S. A. (1994) · Hepatology · doi:10.1002/hep.1840200513 · Cited by 193
Indications and outcome of liver transplantation in tyrosinaemia type 1
Mohan, N., McKiernan, P., Kelly, D. A., Preece, M. A., Green, A., Buckels, J., & Mayer, A. D. (1999) · European Journal of Pediatrics · doi:10.1007/pl00014321 · Cited by 111
Grenier, A., Lescault, A., Laberge, C., Gagné, R., & Marner, O. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90117-6 · Cited by 73
Cited by
Chinsky, J. M., Singh, R., Ficicioglu, C., van Karnebeek, C. D. M., Grompe, M., Mitchell, G., Waisbren, S. E., Gucsavas-Calikoglu, M., Wasserstein, M. P., Coakley, K., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.101 · Cited by 247
NTBC treatment in tyrosinaemia type I: Long‐term outcome in French patients
Masurel‐Paulet, A., Poggi‐Bach, J., Rolland, M. ‐., Bernard, O., Guffon, N., Dobbelaere, D., Sarles, J., de Baulny, H. O., & Touati, G. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0793-1 · Cited by 212
“Both patients had been treated late, after 2 years of age, which is consistent with reports of higher risk of liver carcinomas when the patients are treated late (Holme and Lindstedt 2000).”
BackgroundMethodResultInfluentialCombined Newborn Screening for Succinylacetone, Amino Acids, and Acylcarnitines in Dried Blood Spots
Turgeon, C., Magera, M. J., Allard, P., Tortorelli, S., Gavrilov, D., Oglesbee, D., Raymond, K., Rinaldo, P., & Matern, D. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101949 · Cited by 145
Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec
Larochelle, J., Alvarez, F., Bussières, J.-F., Chevalier, I., Dallaire, L., Dubois, J., Faucher, F., Fenyves, D., Goodyer, P., Grenier, A., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.05.022 · Cited by 137
“2; references [11,12]).”
Self-citationAl-Dhalimy, M., Overturf, K., Finegold, M., & Grompe, M. (2002) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3266 · Cited by 86
Metadata
- Authors
- Holme, E., & Lindstedt, S.
- Venue
- Clinics in Liver Disease
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 4
- Issue
- 4
- Pages
- 805-814
- ISSN
- 1089-3261 (ISSN-L)
- OpenAlex
- W2073398016
- Cited by
- 159
- References
- 7
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NONTRANSPLANT TREATMENT OF TYROSINEMIA. https://app.cochat.ai/papers/10.1016/s1089-3261(05)70142-2
- The paper
- Holme, E., & Lindstedt, S. (2000). NONTRANSPLANT TREATMENT OF TYROSINEMIA. Clinics in Liver Disease. https://doi.org/10.1016/s1089-3261(05)70142-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.